Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Cancer Vaccines

15 Sep 2014 - 16 Sep 2014 - London, UK



Bookmark and Share


Quantify Strategies to Enhance Cancer Vaccine Research and Development

The global therapeutic cancer vaccines market is expected to grow to a value of $7.8 billion by 2019. As companies look to develop new drugs to enter this rapidly growing industry, Cancer Vaccines 2014 will mark the path forward in terms of cancer vaccine research, clinical development and regulation.

SMi Group have worked closely with an expert speaker panel which includes KOLs from Amal Therapeutics, Amgen, DanDrit Biotech, CureVac and Vaccinogen, to put together an exciting conference agenda for the 3rd annual conference taking place on 15th and 16th September in London UK.

This year's programme will feature a mix of case study led presentations, networking opportunities, an interactive workshop and keynote addresses that have been tailored for an audience of professionals working in the cancer vaccine market from drug design through to clinical trials and treatment.

Previous Testimonials Include:

"Great focused meeting. Good range of speakers and topics" – INSERM

"I found the conference very informative and the standard of the presentations was very good. I’m pleased that I attended" - Asterand

Key Speakers Include:

Joseph Melenhorst, Director of the Product Development & Correlative Sciences Laboratory, University Of Pennsylvania

Tom Lillie, Therapeutic Area Head, Oncology, Amgen Ltd

Alex Karlsson-Parra, CSO, Immunicum AB

Birgit Scheel, Director Program Management Oncology, Curevac GmbH

Harpreet Singh, Managing Director, Founder and CSO, Immatics Biotechnologies GmbH

Christian Ottensmeier, Professor in Experimental Cancer Medicine, University Of Southampton

Madiha Derouazi, CEO, Amal Therapeutics

Eric Leire, CEO, DanDrit Biotech

Why Attend in 2014?

Insight into a Perfect Partnership – University of Pennsylvania and Novartis Collaboration! Hear it here first: Assessing techniques involved in removing a patient's T cells and inserting new genetic material to enable the T cells to attack and kill cancer cells

Assessing Oncolytic Vaccines - Reviewing developments from Amgen and Psioxus Therapeutics

What are the key questions in Cancer Immunotherapy? Professor Christian Ottensmeier attacks this question head on!

Evaluating analytical advances for Cancer Vaccines with an insight from Key Opinion Leaders at Immatics GmbH, Vaccinogen and the University of Southampton

To register or download a brochure visit: 

http://www.smi-online.co.uk/goto/2014cancervaccinesevent24.asp 

For further details, contact Sajid Goraya on +44 (0)20 7827 6148 or email sgoraya@smi-online.co.uk 



Further information
Scientific News
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Leukemia’s Surroundings Key to its Growth
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
NIH Seeks Research Applications to Study Zika in Pregnancy, Developing Fetus
Institute has announced that the new effort seeks to understand virus effect on reproduction and child development.
Iron in the Blood Could Cause Cell Damage
Concentrations of iron similar to those delivered through standard treatments can trigger DNA damage within 10 minutes, when given to cells in the laboratory.
Neanderthal DNA Influences Human Disease Risk
Large-scale, evolutionary analysis compares genetic data alongside electronic health records.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!